ClinConnect ClinConnect Logo
Search / Trial NCT06863168

Cigarillo Public Education Messaging for Black Young Adults

Launched by DREXEL UNIVERSITY · Mar 3, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how public education messages about the dangers of cigarillo smoking can affect Black young adults who might be at risk of starting to smoke. The study will have three groups of participants and aims to see if these messages change how they feel about the harmful effects of cigarillos, their expectations about smoking, and their intentions to use cigarillos over a three-month period. Researchers will also explore whether these messages influence actual smoking behaviors, such as starting to smoke or how often they smoke, at one and three months after receiving the messages.

To participate in this trial, you need to be between 18 and 30 years old and identify as non-Hispanic Black or African American. You should not have a history of regular cigarillo use but may be at risk of trying them, or you might currently smoke them occasionally. Participants will receive educational messages and will be asked to fill out surveys to share their thoughts and behaviors regarding cigarillos. It's important to note that this study is not yet recruiting participants, and all materials will be provided in English, so participants should be able to read and communicate in English.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be between 18 to 30 years of age;
  • Self-identify as non-Hispanic Black or African American ethnicity and race, respectively;
  • Must be able to communicate, read, and write in the English language;
  • Have never used cigarillos fairly regularly based on a valid measure but are deemed susceptible to cigarillo smoking based on a valid 4-item susceptibility measure; OR currently smokes cigarillos some days but not every day (i.e., experimentation)
  • And must have no history of fairly regular use of any other tobacco products (i.e., little cigars, large cigars, cigarettes, hookah tobacco, electronic vaping products, smokeless tobacco, and heated tobacco products)
  • Exclusion Criteria:
  • Persons who are younger than 18 years of age or older than 30 years of age.
  • Persons who do not self-identify as a non-Hispanic Black/African American person.
  • Persons who are not deemed susceptible based on a valid susceptibility measure (i.e., not susceptible to cigarillo smoking)
  • Persons who have fairly regular use of any tobacco product (i.e., persons with a former or current established pattern of any tobacco use including cigarillos, little cigars, large cigars, cigarettes, hookah tobacco, electronic vaping products, smokeless tobacco, and heated tobacco products)
  • Persons who are unable to read, write, and communicate in English language. The informed consent and other materials, including surveys, are only available in the English language for this study. Additionally, trained staff members that will communicate and interact with participants for this study can only speak in English.

About Drexel University

Drexel University is a prominent research institution located in Philadelphia, Pennsylvania, known for its commitment to advancing knowledge through innovative research and education. As a clinical trial sponsor, Drexel University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving health outcomes. The university fosters collaborations across various fields, including medicine, engineering, and public health, ensuring a comprehensive approach to addressing complex health challenges. With a focus on ethical standards and participant safety, Drexel University is dedicated to translating research findings into practical applications that enhance community well-being and contribute to the advancement of medical science.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported